World-first trial to assess ‘life-extending’ cannabis-based drug for thousands with aggressive brain tumours
BHP founder member the University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
The ne…
Rheumatology Research Group awarded five year EULAR Centre of Excellence Status
The Rheumatology Research Group (RRG) at BHP founder-member the University of Birmingham has been awarded five-year EULAR Centre of Excellence status for the second time in a row.
EULAR (European Le…
New study aims to improve healthcare for pregnant women with multiple health conditions
BHP founder-member the University of Birmingham is leading a new three-year UK-wide study aimed at improving healthcare and outcomes for pregnant women who have two or more active long-term health co…
UHB and Cambridge University Hospitals win government funding for ground-breaking AI in radiotherapy
A machine learning technology that helps cut the time patients wait for life-saving cancer treatment has been successful in the latest round of the Artificial Intelligence (AI) in Health and Care Awa…
£1.5m funding for youth mental health research
The Institute for Mental Health at BHP founder member the University of Birmingham has been awarded £1.5M from the Wolfson Foundation to fund a research centre focused on supporting youth mental heal…
Urine test for bladder cancer to be developed by University of Birmingham and Nonacus
BHP founder-member the University of Birmingham and Nonacus, a provider of genetic testing products for precision medicine and liquid biopsy, have partnered to develop a non-invasive test for bladder…